Skip to main navigation Skip to search Skip to main content

Personalised prevention: what patients and citizen advocates want for better engagement - a qualitative study

  • European Patients' Forum (EPF)
  • Saxony Liaison Office Brussels, Brussels, Belgium.
  • Cittadinanzattiva APS - Active Citizenship Network (ACN)
  • ‘Sapienza’ University of Rome, Rome, Italy

Research output: Contribution to journalArticleAcademicpeer-review

10 Downloads (Pure)

Abstract

BACKGROUND: Incorporating public and patient perspectives is essential to advancing personalised prevention. Personalised prevention focuses on preventing disease onset, progression, and recurrence by tailoring interventions on the basis of an individual's biological, environmental, behavioural, socioeconomic, and cultural characteristics. This study explored what patients and the public want for better engagement and empowerment in prevention, aiming to develop key considerations across three domains (Research, Care, and Governance), and offering practical points to consider for improving personalised prevention strategies.

METHODS: In cocreation with the European Patients Forum (EPF) and Cittadinanzattiva APS-Active Citizenship Network (ACN), semi-structured individual interviews and focus groups were conducted with 29 participants, comprising of 17 citizen advocates and 12 patients (including advocates) across 16 European countries, with experience in seven distinct disease groups. The participants were recruited through ACN and EPF via newsletters and mailing lists. Thematic analysis was performed via MAXQDA software. This study adhered to the Consolidated Criteria for Reporting Qualitative Research (COREQ).

RESULTS: Findings were clustered into three key themes for better engagement in personalised prevention: (i) Information and Communication, where patients and the public emphasised the need for clear and accessible health information and user-friendly digital platforms; (ii) Representation and Inclusivity, highlighting calls for inclusive research, community engagement, and mental health integration; and (iii) Ethical and Regulatory Considerations, with concerns over equity and the potential shift from solidarity-based care to individual risk assessment, underscoring the need for robust privacy protection and equitable policies.

CONCLUSIONS: Enhancing patient and public engagement in personalised prevention requires more focus on communication, inclusivity, and secure data use. The findings provide actionable insights, promoting systematic engagement across Research, Care, and Governance. Clear information about prevention strategies and treatment options must be accessible, while diverse voices should be represented in decision-making. Collaboration with communities and better use of patient data can enhance prevention efforts. Policies should ensure ethical implementation, address data protection, and promote equity, transparency, and patient and public empowerment in healthcare, ultimately fostering a more inclusive approach to personalised prevention.

Original languageEnglish
Article number3777
Pages (from-to)3777
JournalBMC public health
Volume25
Issue number1
DOIs
Publication statusPublished - Dec 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 16 - Peace, Justice and Strong Institutions
    SDG 16 Peace, Justice and Strong Institutions

Keywords

  • Best practices
  • Community participation
  • Empowerment
  • Patient and public engagement
  • Personalised medicine
  • Personalised prevention
  • Precision health
  • Public health
  • Stakeholder engagement
  • Strategy recommendations

Fingerprint

Dive into the research topics of 'Personalised prevention: what patients and citizen advocates want for better engagement - a qualitative study'. Together they form a unique fingerprint.

Cite this